(2020). Anti-carbamylated protein and peptide antibodies as potential inflammatory joint biomarkers in the relatives of rheumatoid arthritis patients.
Chicago Style (17th ed.) CitationAnti-carbamylated Protein and Peptide Antibodies as Potential Inflammatory Joint Biomarkers in the Relatives of Rheumatoid Arthritis Patients. 2020.
MLA (8th ed.) CitationAnti-carbamylated Protein and Peptide Antibodies as Potential Inflammatory Joint Biomarkers in the Relatives of Rheumatoid Arthritis Patients. 2020.
Warning: These citations may not always be 100% accurate.